natgillin/translations-raw huggingface dataset:
must be designed in such a way that the samples are representative and adjusted to the structure of the susceptible species population to be sampled in the epidemiologically relevant geographical area and the sample size has been calculated to detect a prevalence of 20 % with 95 % confidence in the susceptible species population of that epidemiologically relevant geographical area;
peab olema välja töötatud nii, et valimid esindavad epidemioloogiliselt asjakohases geograafilises piirkonnas uuritavate vastuvõtlike liikide populatsiooni ja on selle populatsiooni struktuurile kohandatud ning valimi suurus on arvutatud viisil, mis võimaldab 95 % kindlusega määrata epidemioloogiliselt asjakohase geograafilise piirkonna vastuvõtlike liikide populatsioonis 20 % esinemissagedust;
Section A is amended as follows:
A jagu muudetakse järgmiselt.
In point 2, the first paragraph is replaced by the following:
Punkti 2 esimene lõik asendatakse järgmisega:
‘The animals have been kept, until dispatch, protected against attacks by vectors in a vector proof establishment for a period of at least 60 days prior to the date of dispatch.’
„Loomi on vähemalt 60 päeva enne lähetamiskuupäeva kaitstud vektorite rünnaku eest vektorikindlas rajatises.”
In point 3, the first paragraph is replaced by the following:
Punkti 3 esimene lõik asendatakse järgmisega:
‘The animals have been kept, until dispatch, in a bluetongue seasonally-free zone during the seasonally vector-free period, defined in accordance with Annex V, or have been protected against attacks by vectors in a vector proof establishment for a period of at least 28 days and were subjected during that period to a serological test according to the OIE Terrestrial Manual to detect antibodies to the bluetongue virus group, with negative results, carried out on samples collected from that animal at least 28 days following the date of the commencement of the period of protection against attacks by vectors or the seasonally vector-free period.’
„Loomi on kuni lähetamiseni hoitud V lisa kohaselt määratletud hooajalise vektoritest vaba perioodi vältel hooajati lammaste katarraalsest palavikust puutumata tsoonis või neid on vektorite rünnaku eest kaitstud vektorikindlas rajatises vähemalt 28 päeva; selle aja jooksul on neile tehtud kooskõlas OIE käsiraamatuga lammaste katarraalse palaviku viiruse rühma antikehade avastamiseks seroloogiline test, mille tulemused on olnud negatiivsed ja mille tarvis on asjaomaselt loomalt proovid võetud vähemalt 28 päeva jooksul pärast vektorite rünnaku eest kaitsmise perioodi algust või hooajalise vektoritest vaba perioodi algust.”
In point 4, the first paragraph is replaced by the following:
Punkti 4 esimene lõik asendatakse järgmisega:
‘The animals have been kept until dispatch in a bluetongue seasonally-free zone during the seasonally vector-free period, defined in accordance with Annex V, or have been protected against attacks by vectors in a vector proof establishment for a period of at least 14 days and were subjected during that period to an agent identification test according to the OIE Terrestrial Manual, with negative results, carried out on samples collected from that animal at least 14 days following the date of commencement of the period of protection against attacks by vectors or the seasonally vector-free period.’
„Loomi on kuni lähetamiseni hoitud V lisa kohaselt määratletud hooajalise vektoritest vaba perioodi vältel hooajati lammaste katarraalsest palavikust puutumata tsoonis või neid on vektorite rünnaku eest kaitstud vektorikindlas rajatises vähemalt 14 päeva; selle aja jooksul on neile tehtud kooskõlas OIE käsiraamatuga haigusetekitaja tuvastamise analüüs, mille tulemused on olnud negatiivsed ja mille tarvis on asjaomaselt loomalt proovid võetud vähemalt 14 päeva jooksul pärast vektorite rünnaku eest kaitsmise perioodi algust või hooajalise vektoritest vaba perioodi algust.”
In Section B, point (b) is replaced by the following:
B jao punkt b asendatakse järgmisega:
they have been protected against attacks by vectors in a vector proof establishment for a period of at least 60 days before commencement of, and during, collection of the semen;’
neid on vektorite rünnaku eest kaitstud vektorikindlas rajatises vähemalt 60 päeva enne sperma kogumise algust ja selle kestel;”;
In Section C, point 2(b) is replaced by the following:
C jao punkti 2 alapunkt b asendatakse järgmisega:
they have been protected against attacks by vectors in a vector proof establishment for at least 60 days before commencement of, and during, collection of the embryos/ova;’
neid on vektorite rünnaku eest kaitstud vektorikindlas rajatises vähemalt 60 päeva enne embrüote/munarakkude kogumise algust ja selle kestel;”.
Commission Regulation (EC) No 790/2009
Komisjoni määrus (EÜ) nr 790/2009,
amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures
millega muudetakse tehnika ja teaduse arenguga kohandamiseks Euroopa Parlamendi ja nõukogu määrust (EÜ) nr 1272/2008, mis käsitleb ainete ja segude klassifitseerimist, märgistamist ja pakendamist
Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 [1], and in particular Article 53 thereof,
võttes arvesse Euroopa Parlamendi ja nõukogu 16. detsembri 2008. aasta määrust (EÜ) nr 1272/2008, mis käsitleb ainete ja segude klassifitseerimist, märgistamist ja pakendamist ning millega muudetakse direktiive 67/548/EMÜ ja 1999/45/EÜ ja tunnistatakse need kehtetuks ning muudetakse määrust (EÜ) nr 1907/2006, [1] eelkõige selle artiklit 53,
Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised classification and labelling of hazardous substances.
Määruse (EÜ) nr 1272/2008 VI lisa 3. osas on esitatud kaks ohtlike ainete ühtse klassifikatsiooni ja märgistuse loendit.
Table 3.1 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008.
Tabelis 3.1 on ohtlike ainete ühtse klassifikatsiooni ja märgistuse loend, mis põhineb määruse (EÜ) nr 1272/2008 I lisa 2.–5. osas sätestatud kriteeriumidel.
Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances [2].
Tabelis 3.2 on ohtlike ainete ühtse klassifikatsiooni ja märgistuse loend, mis põhineb nõukogu 27. juuni 1967. aasta direktiivi nr 67/548/EMÜ (ohtlike ainete liigitamist, pakendamist ja märgistamist käsitlevate õigus- ja haldusnormide ühtlustamise kohta) [2] VI lisas sätestatud kriteeriumidel.
These two lists need to be amended to include updated classifications for substances already subject to harmonised classification and to include new harmonised classifications.
Kõnealust kahte nimekirja on vaja muuta, et lisada selliste ainete ajakohastatud klassifikatsioon, mille puhul ühtne klassifitseerimine juba kehtib, ning ka uute ainete ühtne klassifikatsioon.
In addition, it is necessary to delete entries for certain substances.
Lisaks on vaja välja jätta kanded teatavate ainete kohta.
It is necessary to amend Annex VI to Regulation (EC) No 1272/2008 in order to reflect the recently adopted amendments to Annex I to Directive 67/548/EEC introduced by Commission Directive 2008/58/EC of 21 August 2008 amending, for the purpose of its adaptation to technical progress, for the 30th time, Council Directive 67/548/EEC [3] and by Commission Directive 2009/2/EC of 15 January 2009 amending for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC [4].
Määruse (EÜ) nr 1272/2008 VI lisa on vaja muuta, et kajastada hiljuti vastu võetud direktiivi 67/548/EMÜ I lisa käsitlevaid muudatusi, mis on kehtestatud komisjoni 21. augusti 2008. aasta direktiiviga 2008/58/EÜ, millega muudetakse kolmekümnendat korda tehnilise arenguga kohandamise eesmärgil nõukogu direktiivi 67/548/EMÜ, [3] ja komisjoni 15. jaanuari 2009. aasta direktiiviga 2009/2/EÜ, millega muudetakse kolmekümne esimest korda tehnilise arenguga kohandamise eesmärgil nõukogu direktiivi 67/548/EMÜ [4].
Those measures constitute adaptations to technical and scientific progress within the meaning of Article 53 of Regulation (EC) No 1272/2008.
Kõnealuseid meetmeid käsitatakse tehnika ja teaduse arenguga kohandamisena määruse (EÜ) nr 1272/2008 artikli 53 tähenduses.
Recital (53) of Regulation (EC) No 1272/2008 underlines the fact that full account should be taken of the work and experience accumulated under Directive 67/548/EEC, including the classification and labelling of specific substances listed in Annex I to that Directive.
Määruse (EÜ) nr 1272/2008 põhjenduses 53 rõhutatakse asjaolu, et tuleks täielikult arvesse võtta direktiivi 67/548/EMÜ põhjal tehtud tööd ja omandatud kogemusi, sealhulgas teatavate kõnealuse direktiivi I lisas loetletud ainete klassifiktsiooni ja märgistust.
The harmonised classifications set out in Part 3 of Annex VI to Regulation EC (No) 1272/2008, as amended by this Regulation, should not apply immediately, as a certain period of time will be necessary to allow operators to adapt the labelling and packaging of substances and mixtures to the new classifications.
Määruse (EÜ) nr 1272/2008 VI lisa 3. osas sätestatud ühtset klassifikatsiooni (muudetud käesoleva määrusega) ei tuleks kohaldada viivitamata, kuna on vaja teatud ajavahemikku, et ettevõtjad saaksid ainete ja segude märgistamist ja pakendamist kohandada uue klassifikatsiooniga.
In addition a certain period of time will be necessary to allow operators to comply with registration obligations that are a consequence of the new harmonised classifications for substances classified as carcinogenic, mutagenic or toxic to reproduction, categories 1A and 1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC [5].
Lisaks sellele on vaja teatud ajavahemikku, et ettevõtjad saaksid täita uuest ühtlustatud klassifikatsioonist tulenevaid registreerimiskohustusi ainete puhul, mis on liigitatud 1A või 1B kategooria (tabel 3.1) või 1. ja 2. kategooria (tabel 3.2) kantserogeenideks, mutageenideks või reproduktiivtoksilisteks aineteks, või selliste ainete puhul, mis on väga mürgised veeorganismidele ning mis võivad avaldada pikaajalist veekeskkonda kahjustavat toimet, ning täita eelkõige neid kohustusi, mis on sätestatud Euroopa Parlamendi ja nõukogu 18. detsembri 2006. aasta määruses (EÜ) nr 1907/2006, mis käsitleb kemikaalide registreerimist, hindamist, autoriseerimist ja piiramist (REACH) ja millega asutatakse Euroopa Kemikaaliamet ning muudetakse direktiivi 1999/45/EÜ ja tunnistatakse kehtetuks nõukogu määrus (EMÜ) nr 793/93, komisjoni määrus (EÜ) nr 1488/94 ning samuti nõukogu direktiiv 76/769/EMÜ ja komisjoni direktiivid 91/155/EMÜ, 93/67/EMÜ, 93/105/EÜ ja 2000/21/EÜ [5].
In the case of the substances in this Regulation which are updated or added to Part 3 of Annex VI to Regulation (EC) No 1272/2008 it is also appropriate that the obligation to classify substances in accordance with the harmonised classifications set out in Part 3 of Annex VI to Regulation EC (No) 1272/2008, as amended by this Regulation, should coincide with the date set out in Article 23 of Regulation (EC) No 1907/2006 and therefore this regulation should apply from 1 December 2010.
Käesolevas määruses käsitletud selliste ainete puhul, mida on ajakohastatud või mis on lisatud määruse (EÜ) nr 1272/2008 VI lisa 3. osasse, on samuti asjakohane, et kohustus klassifitseerida aineid vastavalt määruse (EÜ) nr 1272/2008 VI lisa 3. osas sätestatud ühtsele klassifikatsioonile (muudetud käesoleva määrusega) peaks kokku langema määruse (EÜ) nr 1907/2006 artiklis 23 sätestatud kuupäevaga ning seepärast tuleks käesolevat määrust kohaldada 1. detsembrist 2010.
Suppliers should have the possibility of applying the harmonised classifications set out in Part 3 of Annex VI to Regulation EC (No) 1272/2008, as amended by this Regulation, and of adapting the labelling and packaging accordingly before 1 December 2010, as provided for in Regulation (EC) No 1272/2008.
Tarnijatel peaks olema võimalus kohaldada määruse (EÜ) nr 1272/2008 VI lisa 3. osas sätestatud ühtset klassifikatsiooni (muudetud käesoleva määrusega) ning kohandada märgistamist ja pakendamist vastavalt alates 1. detsembrist 2010, nagu on ette nähtud määrusega (EÜ) nr 1272/2008.
The published version of Directive 2009/2/EC mistakenly contained entry No. 607-674-00-0 (branched C10-alkyl benzoates), therefore, it is appropriate to correct this clerical error and not include this entry in Annex VI to Regulation (EC) No 1272/2008.
Kuna direktiivi 2009/2/EÜ avaldatud versioonis on ekslikult kanne nr 607-674-00-0 (hargahelaga C10-alküülbensoaadid), on asjakohane see trükiviga parandada ning kõnealune kanne määruse (EÜ) nr 1272/2008 VI lisast välja jätta.
Part 3 of Annex VI to Regulation (EC) No 1272/2008 is amended as follows:
Määruse (EÜ) nr 1272/2008 VI lisa 3. osa muudetakse järgmiselt:
Table 3.1 is amended as follows:
tabelit 3.1 muudetakse järgmiselt:
The entries corresponding to the entries set out in Annex I are replaced by the entries set out in that Annex;
I lisas esitatud kannetele vastavad kanded asendatakse kõnealuse lisa kannetega;
The entries set out in Annex II are inserted in accordance with the order of the entries set out in Table 3.1;
II lisas esitatud kanded lisatakse vastavalt tabelis 3.1 esitatud kannete järjekorrale;
The entries set out in Annex III are deleted from Table 3.1;
III lisas esitatud kanded jäetakse tabelist 3.1 välja;
Table 3.2 is amended as follows:
tabelit 3.2 muudetakse järgmiselt:
The entries corresponding to the entries set out in Annex IV are replaced by the entries set out in that Annex;
IV lisas esitatud kannetele vastavad kanded asendatakse kõnealuse lisa kannetega;
The entries set out in Annex V are inserted in accordance with the order of the entries set out in Table 3.2;
V lisas esitatud kanded lisatakse vastavalt tabelis 3.2 esitatud kannete järjekorrale;
Article 1 shall apply from 1 December 2010.
Artiklit 1 kohaldatakse alates 1. detsembrist 2010.
The harmonised classifications set out in Part 3 of Annex VI to Regulation EC (No) 1272/2008, as amended by this Regulation, may be applied before 1 December 2010.
Määruse (EÜ) nr 1272/2008 VI lisa 3. osas sätestatud ühtset klassifikatsiooni (muudetud käesoleva määrusega) võib kohaldada enne 1. detsembrit 2010.
Done at Brussels, 10 August 2009.
Brüssel, 10. august 2009.
OJ L 246, 15.9.2008, p. 1
ELT L 246, 15.9.2008, lk 1.
OJ L 11, 16.1.2009, p. 6.
ELT L 11, 16.1.2009, lk 6.
OJ L 136, 29.5.2007, p. 3.
ELT L 136, 29.5.2007, lk 3.
International Chemical Identification
Rahvusvaheline keemiline tunnus
Specific Conc. Limits M-factors
Konkreetsed sisalduse piirväärtused, korrutustegurid
Hazard Class and Category Code(s)
Ohuklassi ja -kategooria kood(id)
Hazard statement Code(s)
Ohulause kood(id)
Pictogram, Signal Word Code(s)
Piktogrammide ja tunnussõnade kood(id)
Suppl. Hazard statement Code(s)
Täiendava ohulause kood(id)
reaction mass of: (1'α, 3'α, 6'α)-2,2,3', 7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane);
reaction mass of: (1'α,3'α,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane);
(1'α, 3'β, 6'α)-2,2,3', 7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane)
(1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane)
(1α,4α,4aβ, 5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene
(1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene
2,2'-((3,3', 5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane
2,2'-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane
racemate comprising (R)-α-cyano-3-phenoxybenzyl (1S, 3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;
racemate comprising (R)-α-cyano-3-phenoxybenzyl (1S,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;
(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
(S)-α-cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
(RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which ‘octyl’ is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups
(RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which „octyl” is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups
α, α, α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0,5 ppm NPDA);
α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0,5 ppm NPDA);
[containing ≥ 0.1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
3', 4'-dichloropropionanilide
3',4'-dichloropropionanilide
It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately –20 °C to 196 °C (–4 °F to 384 °F).]
It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately –20 °C to 196 °C(–4 °F to 384 °F).]
tert-butyl (1R, 5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate
tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate
3-(][(4-methylphenyl)sulfonyl]carbamoyl[amino)phenyl 4-methylbenzenesulfonate
3-([(4-methylphenyl)sulfonyl]carbamoylamino)phenyl 4-methylbenzenesulfonate
complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O,2<n<3)
complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O, 2 < n < 3)
reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr: DTBS= 1,0: 1,0 to 1,0: 1,5
reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr: DTBS = 1,0: 1,0 to 1,0: 1,5
(E)-(7R, 11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol
(E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol
reaction mass of 50-95 % of (2R, 3aS, 5aR, 5bS, 9S, 13S, 14R, 16aS, 16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S, 3aR, 5aS, 5bS, 9S, 13S, 14R, 16aS, 16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1]
reaction mass of 50-95 % of (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1]
1-]benzyl[2-(2-methoxyphenoxy)ethyl]amino[-3-(9H-carbazol-4-yloxy)propan-2-ol
1-benzyl[2-(2-methoxyphenoxy)ethyl]amino-3-(9H-carbazol-4-yloxy)propan-2-ol
(2R, 3S, 4R, 5R, 7R, 9R, 10R, 11S, 12S, 13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane
(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane
(3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)
(+/–)-(R*, R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;
(+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;
(1R, 4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene
(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene
4,4'-(1-]4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl[ethylidene)diphenol
4,4'-(1-4-[1-(4-hydroxyphenyl)-1-methylethyl]phenylethylidene)diphenol
2,2', 6,6'-tetrabromo-4,4'-isopropylidenediphenol
2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol
reaction mass of: (1RS, 2RS, 3SR, 6RS, 9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;
reaction mass of: (1RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;
(1RS, 2RS, 3RS, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;
(1RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;
(1RS, 2RS, 4SR, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde
(1RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde
reaction mass of: (1R*, 2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene;
reaction mass of: (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene;
(2R*, 3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene
(2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene
N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H), 1'(3'H)-isobenzofuran]-3'-one
N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H),1'(3'H)-isobenzofuran]-3'-one
3,4,3', 4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione
3,4,3',4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione
(4aR*, 8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one
(4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one
4,4', 5,5', 6,6', 7,7'-octachloro-(2,2')biisoindolyl-1,1', 3,3'-tetraone
4,4',5,5',6,6',7,7'-octachloro-(2,2')biisoindolyl-1,1',3,3'-tetraone
2-](EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl[-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one
2-(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one
(RS)-(EZ)-2-]1-[(2E)-3-chloroallyloxyimino]propyl[-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one
(RS)-(EZ)-2-1-[(2E)-3-chloroallyloxyimino]propyl-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one
(+)-(1S, 2S, 3S, 5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)
(+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)
(2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one
(2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one